Risk of Depression after 5 Alpha Reductase Inhibitor Medication: Meta-Analysis

PURPOSE: Although five-alpha reductase inhibitor (5-ARI) is one of standard treatment for benign prostatic hyperplasia (BPH) or alopecia, potential complications after 5-ARI have been issues recently. This study aimed to investigate the risk of depression after taking 5-ARI and to quantify the risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jae Heon, Shim, Sung Ryul, Khandwala, Yash, Del Giudice, Francesco, Sorensen, Simon, Chung, Benjamin I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Sexual Medicine and Andrology 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502319/
https://www.ncbi.nlm.nih.gov/pubmed/31190484
http://dx.doi.org/10.5534/wjmh.190046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502319/
https://www.ncbi.nlm.nih.gov/pubmed/31190484
http://dx.doi.org/10.5534/wjmh.190046

Ejemplares similares